Company Profile
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.
Latest News
Oil prices sink as US-Iran pause fuels fresh Hormuz hopes
Dreame Technology Redefines Hands-free Cleaning with the Launch of the Dreame D30 Ultra Robot Vacuum
Netflix Is Down 41% in 1 Year. Could the Sell-Off Be Nearing an End?
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Website | https://www.otsuka.com |
| Audit Risk | 1 |
| Board Risk | 9 |
| Overall Risk | 9 |
| Market Cap | 5.95T |
| Trailing P/E | 16.53 |
| Forward P/E | 21.81 |
| Dividend Rate | 140 |
| Dividend Yield | 1.26% |
| Trailing Annual Div. Rate | 140 |
| Trailing Annual Div. Yield | 1.26% |
| Trailing EPS | 684.92 |
| Forward EPS | 519.18 |
| Book Value | 5,894.25 |
| Price-to-Book | 1.92 |
| Enterprise-to-Revenue | 2.23 |
| Enterprise-to-EBITDA | 9.43 |
| Ex-Dividend Date | 12/29/2026 |
| Earnings Date | 07/31/2026 |
| Earnings Call Date | |
| Revenue Average | 643.66B |
| Revenue Low | 621.00B |
| Revenue High | 662.87B |